Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 13
1.2 List of Figures 20
2 Introduction 23
2.1 What Is This Report
About? 23
3 Definitions of Markets Covered in the Report 24
3.1
Cardiovascular Devices 24
3.2 Cardiac Rhythm Management 24
3.2.1
Pacemakers 24
3.2.2 Implantable Cardioverter Defibrillator (ICD) 24
3.2.3 Cardiovascular Pacing and ICD Leads 25
3.2.4 Cardiac
Resynchronization Therapy 25
3.3 Cardiovascular monitoring and diagnostic
devices 25
3.3.1 ECG Monitoring Equipment 25
3.3.2 ECG Stress Testing
Systems 25
3.3.3 Holter Monitoring Systems 25
3.3.4 Event Monitoring
Systems 25
3.4 Cardiovascular prosthetic device 26
3.4.1 Prosthetic
heart valves 26
3.4.2 Cardiac Valve Repair 26
3.4.3 Cardiac assist
devices 26
3.5 Cardiovascular Surgery 27
3.5.1 Beating Heart Systems
27
3.5.2 Perfusion Systems 27
3.5.3 Cardiac Ablation Devices 27
3.5.4 Cardiopulmonary Bypass Equipment 27
3.5.5 Perfusion Disposables
27
3.6 Electrophysiology 28
3.6.1 Electrophysiology diagnostic
catheter 28
3.6.2 Electrophysiology ablation catheter 28
3.6.3
Electrophysiology lab systems 28
3.7 Interventional cardiology 28
3.7.1 Coronary Stents 28
3.7.2 Cardiac Catheters 28
3.7.3 Percutaneous
Transluminal Coronary Balloon (PTCA) Balloon Catheters 29
3.7.4 Coronary
Guidewire 29
3.7.5 Arteriotomy Closure Devices 29
3.8 Peripheral
vascular devices 29
3.8.1 Peripheral Vascular Stents 30
3.8.2 Inferior
Vena Cava Filter 30
3.8.3 PTA Balloon 30
3.8.4 Aortic Stent Graft
30
3.8.5 Embolic Protection Device 30
3.8.6 Synthetic Surgical Grafts
30
3.8.7 Peripheral Guidewire 30
4 Healthcare Sector Review 31
4.1
Healthcare Expenditure 31
4.2 Healthcare Infrastructure 32
4.3
Healthcare Policy 34
4.4 United Kingdom Healthcare Trade Statistics 35
5 Regulation System 36
5.1 Medical Equipment Approval Process 36
5.1.1
Classification of Medical Devices 36
5.1.2 Conformity Assessment Process
44
5.2 Medical Device approval fee 48
5.3 Post Market Surveillance
(PMS) 49
6 Pricing and Reimbursement 50
6.1 Market Pricing 50
6.2
Government Policies for Reimbursement 50
7 Distribution Structure 51
8
Cardiovascular Devices In United Kingdom 52
8.1 Cardiovascular Devices,
Cross Country Comparison, Revenue ($ mn), 2000-2015 52
8.2 Cardiovascular
Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015 53
8.3
Cardiovascular Devices, United Kingdom, Category Volume (Units), 2000-2015
59
8.4 Cardiovascular Devices, United Kingdom, Company Share (2007-2008)
61
9 Cardiac Rhythm Management In United Kingdom 62
9.1 Cardiac Rhythm
Management Overall Revenue (2000-2015) 62
9.1.1 Cardiac Resynchronisation
Therapy Overall Revenue (2000-2015) 64
9.1.2 Implantable Cardioverter
Defibrillator Overall Revenue (2000-2015) 66
9.1.3 Pacemaker Overall
Revenue (2000-2015) 68
9.2 Cardiac Rhythm Management Overall Volume
(2000-2015) 70
9.2.1 Cardiac Resynchronisation Therapy Overall Volume
(2000-2015) 72
9.2.2 Implantable Cardioverter Defibrillator Overall Volume
(2000-2015) 74
9.2.3 Pacemaker Overall Volume (2000-2015) 76
9.3
Cardiac Rhythm Management Average Price (2000-2015) 78
9.4 Cardiac Rhythm
Management Distribution Share (2007-2008) 79
9.5 Cardiac Rhythm
Management, United Kingdom, Company Share (2007-2008) 80
10 Cardiovascular
Monitoring and Diagnostic Devices In United Kingdom 81
10.1 Cardiovascular
Monitoring and Diagnostic Devices Overall Revenue (2000-2015) 81
10.2
Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
84
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price
(2000-2015) 86
10.4 Cardiovascular Monitoring and Diagnostic Devices
Distribution Share (2007-2008) 87
10.5 Cardiovascular Monitoring and
Diagnostic Devices, United Kingdom, Company Share (2007-2008) 88
11
Cardiovascular Prosthetic Devices In United Kingdom 89
11.1 Cardiovascular
Prosthetic Devices Overall Revenue (2000-2015) 89
11.1.1 Cardiac Assist
Devices Overall Revenue (2000-2015) 91
11.1.2 Prosthetic Heart Valve
Overall Revenue (2000-2015) 93
11.2 Cardiovascular Prosthetic Devices
Overall Volume (2000-2015) 95
11.2.1 Cardiac Assist Devices Overall Volume
(2000-2015) 97
11.2.2 Prosthetic Heart Valve Overall Volume (2000-2015)
99
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015)
101
11.4 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
102
11.5 Cardiovascular Prosthetic Devices, United Kingdom, Company Share
(2007-2008) 103
12 Cardiovascular Surgery In United Kingdom 104
12.1
Cardiovascular Surgery Overall Revenue (2000-2015) 104
12.1.1 Perfusion
Disposables Overall Revenue (2000-2015) 106
12.2 Cardiovascular Surgery
Overall Volume (2000-2015) 108
12.2.1 Perfusion Disposables Overall Volume
(2000-2015) 109
12.3 Cardiovascular Surgery Average Price (2000-2015)
111
12.4 Cardiovascular Surgery Distribution Share (2007-2008) 112
12.5 Cardiovascular Surgery, United Kingdom, Company Share (2007-2008) 113
13 Electrophysiology In United Kingdom 114
13.1 Electrophysiology Overall
Revenue (2000-2015) 114
13.2 Electrophysiology Overall Volume (2000-2015)
116
13.3 Electrophysiology Average Price (2000-2015) 118
13.4
Electrophysiology Distribution Share (2007-2008) 119
13.5
Electrophysiology, United Kingdom, Company Share (2007-2008) 120
14
Interventional Cardiology In United Kingdom 121
14.1 Interventional
Cardiology Overall Revenue (2000-2015) 121
14.1.1 Cardiac Catheter Overall
Revenue (2000-2015) 124
14.1.2 Coronary Stent Overall Revenue (2000-2015)
126
14.1.3 PTCA Balloon Overall Revenue (2000-2015) 128
14.2
Interventional Cardiology Overall Volume (2000-2015) 130
14.2.1 Cardiac
Catheter Overall Volume (2000-2015) 132
14.2.2 Coronary Stent Overall
Volume (2000-2015) 134
14.2.3 PTCA Balloon Overall Volume (2000-2015)
136
14.3 Interventional Cardiology Average Price (2000-2015) 138
14.4
Interventional Cardiology Distribution Share (2007-2008) 140
14.5
Interventional Cardiology, United Kingdom, Company Share (2007-2008) 141
15 Peripheral Vascular Devices In United Kingdom 142
15.1 Peripheral
Vascular Devices Overall Revenue (2000-2015) 142
15.2 Peripheral Vascular
Devices Overall Volume (2000-2015) 146
15.3 Peripheral Vascular Devices
Average Price (2000-2015) 150
15.4 Peripheral Vascular Devices
Distribution Share (2007-2008) 151
15.5 Peripheral Vascular Devices,
United Kingdom, Company Share (2007-2008) 152
16 Overview of Key Companies
in United Kingdom Cardiovascular Devices Market 153
16.1 Medtronic, Inc.
153
16.1.1 Company Overview 153
16.1.2 Value Chain Analysis 154
16.1.3 Medtronic, Inc. Pipeline Products 156
16.2 Cordis Corporation
164
16.2.1 Company Overview 164
16.2.2 Cordis Corporation Pipeline
Products 164
16.3 Boston Scientific Corporation 166
16.3.1 Company
Overview 166
16.3.2 Value Chain Analysis 166
16.3.3 Boston Scientific
Corporation Pipeline Products 169
16.4 St. Jude Medical Inc. 175
16.4.1 Company Overview 175
16.4.2 Value Chain Analysis 175
16.4.3 St.
Jude Medical Inc. Pipeline Products 178
16.5 Terumo Corporation 181
16.5.1 Company Overview 181
16.5.2 Value Chain Analysis 181
16.5.3
Terumo Corporation Pipeline Products 183
16.6 Sorin S.p.A. 185
16.6.1
Company Overview 185
16.6.2 Value Chain Analysis 185
16.6.3 Sorin
Group Pipeline Products 188
16.7 Thoratec Corporation 192
16.7.1
Company Overview 192
16.7.2 Value Chain Analysis 193
16.7.3 Thoratec
Corporation Pipeline Products 195
16.8 Smiths Medical 197
16.8.1
Company Overview 197
16.8.2 Value Chain Analysis 198
16.9 Philips
Healthcare 200
16.9.1 Company Overview 200
16.9.2 Value Chain Analysis
201
16.9.3 Philips Medical Systems Pipeline Products 203
16.10 OSI
Systems, Inc. 205
16.10.1 Company Overview 205
16.10.2 Value Chain
Analysis 206
16.11 Nihon Kohden Corporation 208
16.11.1 Company
Overview 208
16.11.2 Value Chain Analysis 209
16.12 MAQUET GmbH & Co.
KG 211
16.12.1 Company Overview 211
16.13 Invatec S.r.l. 212
16.13.1 Company Overview 212
16.13.2 Invatec S.r.l. Pipeline Products
212
16.14 GE Healthcare 216
16.14.1 Company Overview 216
16.15
Fukuda Denshi Co., Ltd. 216
16.15.1 Company Overview 216
16.16 ev3
Inc. 217
16.16.1 Company Overview 217
16.16.2 Value Chain Analysis
218
16.16.3 ev3 Inc. Pipeline Products 220
16.17 Edwards Lifesciences
Corporation 222
16.17.1 Company Overview 222
16.17.2 Value Chain
Analysis 223
16.17.3 Edwards Lifesciences Corporation Pipeline Products
225
16.18 Datascope Corporation 228
16.18.1 Company Overview 228
16.18.2 Value Chain Analysis 228
16.19 CryoCath Technologies Inc. 231
16.19.1 Company Overview 231
16.19.2 CryoCath Technologies Inc. Pipeline
Products 231
16.20 Cardiac Science Corporation 233
16.20.1 Company
Overview 233
16.20.2 Value Chain Analysis 234
16.21 Card Guard AG
236
16.21.1 Company Overview 236
16.21.2 Card Guard AG Pipeline
Products 236
16.22 C.R. Bard, Inc. 237
16.22.1 Company Overview
237
16.22.2 Value Chain Analysis 238
16.22.3 C.R. Bard, Inc. Pipeline
Products 240
16.23 BIOTRONIK GmbH & Co. KG 242
16.23.1 Company
Overview 242
16.23.2 BIOTRONIK GmbH & Co. KG Pipeline Products 242
16.24 Biosense Webster, Inc. 244
16.24.1 Company Overview 244
16.25
AtriCure, Inc. 245
16.25.1 Company Overview 245
16.25.2 AtriCure, Inc.
Pipeline Products 245
16.26 Arrow International, Inc. 247
16.26.1
Company Overview 247
16.26.2 Value Chain Analysis 248
16.26.3 Arrow
International, Inc. Pipeline Products 250
16.27 ABIOMED, Inc. 251
16.27.1 Company Overview 251
16.27.2 Value Chain Analysis 252
16.27.3
ABIOMED, Inc. Pipeline Products 254
16.28 Abbott Laboratories 256
16.28.1 Company Overview 256
16.28.2 Value Chain Analysis 257
16.28.3
Abbott Laboratories Pipeline Products 259
16.29 APC Medical Ltd. 261
16.29.1 Company Overview 261
16.30 Biocompatibles International plc
261
16.30.1 Company Overview 261
16.31 AorTech International plc
261
16.31.1 Company Overview 261
16.31.2 AorTech International plc
Pipeline Products 262
16.32 CardioDigital Ltd 263
16.32.1 Company
Overview 263
16.33 Cardiak Ltd. 263
16.33.1 Company Overview 263
16.33.2 Cardiak Ltd. Pipeline Products 263
16.34 Advanced Medical
Diagnostics Group Limited 265
16.34.1 Company Overview 265
16.35
Huntleigh Technology PLC 265
16.35.1 Company Overview 265
16.36
Tayside Flow Technologies Limited 266
16.36.1 Company Overview 266
16.36.2 Tayside Flow Technologies Limited Pipeline Products 266
16.37
Microsulis Medical Limited 268
16.37.1 Company Overview 268
16.38
Cambridge Theranostics Ltd. 268
16.38.1 Company Overview 268
16.39
Cardio Analytics 269
16.39.1 Company Overview 269
16.40 Gaeltec Ltd.
269
16.40.1 Company Overview 269
16.41 Veryan Medical 270
16.41.1
Company Overview 270
16.41.2 Veryan Medical Pipeline Products 270
16.42 Vascular Concepts Group 271
16.42.1 Company Overview 271
16.42.2
Vascular Concepts Group Pipeline Products 271
16.43 DPI Medical Ltd
273
16.43.1 Company Overview 273
16.44 Arizant UK Ltd. 273
16.44.1
Company Overview 273
16.45 White Medical 273
16.45.1 Company Overview
273
16.46 Schuco International (London) Ltd 274
16.46.1 Company
Overview 274
16.47 Response Medical Equipment Limited 274
16.47.1
Company Overview 274
16.48 Cardionetics Limited 274
16.48.1 Company
Overview 274
16.49 DEKA Research & Development Corporation 275
16.49.1
Company Overview 275
16.50 CardioLogic Ltd Company Profile 275
16.50.1
Company Overview 275
16.51 Chalice Medical Limited Company Profile 275
16.51.1 Company Overview 275
16.52 Deltex Medical Group plc Company
Profile 276
16.52.1 Company Overview 276
16.53 Kimal plc 278
16.53.1 Company Overview 278
16.54 LiDCO Group Plc 279
16.54.1 Company
Overview 279
16.55 LiDCO Group Plc Pipeline Products 279
16.56 Lombard
Medical Technologies PLC 281
16.56.1 Company Overview 281
16.56.2
Lombard Medical Technologies PLC Pipeline Products 281
16.57 VASCUTEK Ltd
283
16.57.1 Company Overview 283
17 Recent Developments 284
17.1
Strategy And Business Planning 284
17.1.1 May 05, 2009: GE Healthcare
Plans New Business Investment Initiative 284
17.1.2 Mar 15, 2009: GE
Healthcare Plan Would Layoff 175 Jobs 284
17.2 Corporate Communications
284
17.2.1 Apr 02, 2009: GE Healthcare Appoints William Carrano As Vice
President, Strategic Business Management, Ultrasound 284
17.2.2 Mar 25,
2009: AorTech Appoints Ian Griffiths As COO 285
17.2.3 Mar 19, 2009: GE
Healthcare Medical Diagnostics Appoints President And CEO 285
17.3 Legal
and Regulatory 285
17.3.1 Jan 09, 2009: CoreValve Prevails In UK Patent
Infringement Action With Edwards Lifesciences 285
17.3.2 Jan 09, 2009:
Edwards Lifesciences' Transcatheter Valve Patent Found Valid In UK Court
286
17.4 Government and Public Interest 286
17.4.1 Apr 24, 2009: MHRA
Advises On Vigilance, Reporting For IVC Filters 286
17.4.2 Feb 25, 2009:
NICE Appraisal Of Endovascular Stent Grafts For Abdominal Aortic Aneurysms
287
17.5 Product News 287
17.5.1 Mar 18, 2009: Dot Medical Offers
Lifevest, The Worlds' First Wearable Cardiac Defibrillator 287
17.5.2 Feb
19, 2009: Cook Medical Announces First-Of-Its-Kind Procedure With Zenith
Helical Branch Iliac Endovascular Graft 288
17.5.3 Feb 17, 2009: HDR
Brachytherapy Treatment That Enables Prostate Cancer Patients To Avoid
Overnight Hospital Stay Is Completed By Bristol Team 288
18 Appendix
290
18.1 Global Markets Direct Research Methodology 290
18.2 Coverage
291
18.3 Secondary Research 291
18.4 Primary Research 292
18.5
Models 292
18.6 Forecasts 293
18.7 Expert Panel Validation 293
18.8 Currency Conversion 294
18.9 Contact Us 295
18.10 Disclaimer
295
1.1 List of Tables
Table 1: Number of Doctor by
Specialty in UK, 2003 - 2007 33
Table 2: United Kingdom Healthcare Trade
Statistics, 2001-2006 35
Table 3: Medical Device Approval Fee in UK, 2006
49
Table 4: Cardiovascular Devices, Cross Country Comparison, Revenue
($ mn), 2000-2015 52
Table 5: Cardiovascular Devices, United Kingdom,
Overall Revenue ($ mn), 2000-2015 53
Table 6: Cardiovascular Devices,
United Kingdom, Cross-Category Analysis, 2000-2015 54
Table 7:
Cardiovascular Devices, United Kingdom, Overall Revenue ($ mn), Historic,
2000-2008 56
Table 8: Cardiovascular Devices, United Kingdom, Overall
Revenue ($ mn), Forecast, 2008-2015 58
Table 9: Cardiovascular
Devices, United Kingdom, Category Volume (Units), 2000-2015 59
Table 10:
Cardiovascular Devices, United Kingdom, Category Volume (Units), Historic,
2000-2008 59
Table 11: Cardiovascular Devices, United Kingdom,
Category Volume (Units), Forecast, 2008-2015 60
Table 12:
Cardiovascular Devices, United Kingdom, Company Share by Revenue ($ mn),
2007-2008 61
Table 13: Cardiac Rhythm Management, United Kingdom,
Revenue ($ mn) by Segment, Historic, 2000-2008 62
Table 14: Cardiac
Rhythm Management, United Kingdom, Revenue ($ mn) by Segment, Forecast,
2008-2015 63
Table 15: Cardiac Resynchronisation Therapy, United
Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 64
Table 16:
Cardiac Resynchronisation Therapy, United Kingdom, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 65
Table 17: Implantable
Cardioverter Defibrillator, United Kingdom, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 66
Table 18: Implantable Cardioverter
Defibrillator, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 67
Table 19: Pacemaker, United Kingdom, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 68
Table 20: Pacemaker, United
Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 69
Table 21:
Cardiac Rhythm Management, United Kingdom, Volume (Units) by Segment,
Historic, 2000-2008 70
Table 22: Cardiac Rhythm Management, United
Kingdom, Volume (Units) by Segment, Forecast, 2008-2015 71
Table 23:
Cardiac Resynchronisation Therapy, United Kingdom, Volume (Units) by
Sub-Segment, Historic, 2000-2008 72
Table 24: Cardiac
Resynchronisation Therapy, United Kingdom, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 73
Table 25: Implantable Cardioverter
Defibrillator, United Kingdom, Volume (Units) by Sub-Segment, Historic,
2000-2008 74
Table 26: Implantable Cardioverter Defibrillator, United
Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015 75
Table 27:
Pacemaker, United Kingdom, Volume (Units) by Sub-Segment, Historic,
2000-2008 76
Table 28: Pacemaker, United Kingdom, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 77
Table 29: Cardiac Rhythm
Management, United Kingdom, Average Price ($), Historic, 2000-2008 78
Table 30: Cardiac Rhythm Management, United Kingdom, Average Price ($),
Forecast, 2008-2015 78
Table 31: Cardiac Rhythm Management, United
Kingdom, Distribution Share by Revenue ($mn), 2007-2008 79
Table 32:
Cardiac Rhythm Management, United Kingdom, Company Share by Revenue ($ mn),
2007-2008 80
Table 33: Cardiovascular Monitoring and Diagnostic
Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008 82
Table 34: Cardiovascular Monitoring and Diagnostic Devices, United
Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015 83
Table 35:
Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Volume
(Units) by Segment, Historic, 2000-2008 84
Table 36: Cardiovascular
Monitoring and Diagnostic Devices, United Kingdom, Volume (Units) by Segment,
Forecast, 2008-2015 85
Table 37: Cardiovascular Monitoring and
Diagnostic Devices, United Kingdom, Average Price ($), Historic, 2000-2008
86
Table 38: Cardiovascular Monitoring and Diagnostic Devices, United
Kingdom, Average Price ($), Forecast, 2008-2015 86
Table 39:
Cardiovascular Monitoring and Diagnostic Devices, United Kingdom, Distribution
Share by Revenue ($mn), 2007-2008 87
Table 40: Cardiovascular
Monitoring and Diagnostic Devices, United Kingdom, Company Share by Revenue ($
mn), 2007-2008 88
Table 41: Cardiovascular Prosthetic Devices, United
Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008 89
Table 42:
Cardiovascular Prosthetic Devices, United Kingdom, Revenue ($ mn) by Segment,
Forecast, 2008-2015 90
Table 43: Cardiac Assist Devices, United
Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 91
Table 44:
Cardiac Assist Devices, United Kingdom, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 92
Table 45: Prosthetic Heart Valve, United
Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 93
Table 46:
Prosthetic Heart Valve, United Kingdom, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 94
Table 47: Cardiovascular Prosthetic Devices,
United Kingdom, Volume (Units) by Segment, Historic, 2000-2008 95
Table
48: Cardiovascular Prosthetic Devices, United Kingdom, Volume (Units) by
Segment, Forecast, 2008-2015 96
Table 49: Cardiac Assist Devices,
United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008 97
Table 50: Cardiac Assist Devices, United Kingdom, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 98
Table 51: Prosthetic Heart Valve,
United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008 99
Table 52: Prosthetic Heart Valve, United Kingdom, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 100
Table 53: Cardiovascular
Prosthetic Devices, United Kingdom, Average Price ($), Historic, 2000-2008
101
Table 54: Cardiovascular Prosthetic Devices, United Kingdom,
Average Price ($), Forecast, 2008-2015 101
Table 55: Cardiovascular
Prosthetic Devices, United Kingdom, Distribution Share by Revenue ($mn),
2007-2008 102
Table 56: Cardiovascular Prosthetic Devices, United
Kingdom, Company Share by Revenue ($ mn), 2007-2008 103
Table 57:
Cardiovascular Surgery, United Kingdom, Revenue ($ mn) by Segment, Historic,
2000-2008 104
Table 58: Cardiovascular Surgery, United Kingdom,
Revenue ($ mn) by Segment, Forecast, 2008-2015 105
Table 59:
Perfusion Disposables, United Kingdom, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 106
Table 60: Perfusion Disposables, United
Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 107
Table 61:
Cardiovascular Surgery, United Kingdom, Volume (Units) by Segment,
Historic, 2000-2008 108
Table 62: Cardiovascular Surgery, United
Kingdom, Volume (Units) by Segment, Forecast, 2008-2015 108
Table 63:
Perfusion Disposables, United Kingdom, Volume (Units) by Sub-Segment,
Historic, 2000-2008 109
Table 64: Perfusion Disposables, United
Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015 110
Table 65:
Cardiovascular Surgery, United Kingdom, Average Price ($), Historic,
2000-2008 111
Table 66: Cardiovascular Surgery, United Kingdom,
Average Price ($), Forecast, 2008-2015 111
Table 67: Cardiovascular
Surgery, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
112
Table 68: Cardiovascular Surgery, United Kingdom, Company Share
by Revenue ($ mn), 2007-2008 113
Table 69: Electrophysiology, United
Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008 114
Table 70:
Electrophysiology, United Kingdom, Revenue ($ mn) by Segment, Forecast,
2008-2015 115
Table 71: Electrophysiology, United Kingdom, Volume
(Units) by Segment, Historic, 2000-2008 116
Table 72:
Electrophysiology, United Kingdom, Volume (Units) by Segment, Forecast,
2008-2015 117
Table 73: Electrophysiology, United Kingdom, Average
Price ($), Historic, 2000-2008 118
Table 74: Electrophysiology,
United Kingdom, Average Price ($), Forecast, 2008-2015 118
Table 75:
Electrophysiology, United Kingdom, Distribution Share by Revenue ($mn),
2007-2008 119
Table 76: Electrophysiology, United Kingdom, Company
Share by Revenue ($ mn), 2007-2008 120
Table 77: Interventional
Cardiology, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
122
Table 78: Interventional Cardiology, United Kingdom, Revenue ($
mn) by Segment, Forecast, 2008-2015 123
Table 79: Cardiac Catheter,
United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 124
Table 80: Cardiac Catheter, United Kingdom, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 125
Table 81: Coronary Stent, United
Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 126
Table 82:
Coronary Stent, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 127
Table 83: PTCA Balloon, United Kingdom, Revenue ($ mn)
by Sub-Segment, Historic, 2000-2008 128
Table 84: PTCA Balloon,
United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 129
Table 85: Interventional Cardiology, United Kingdom, Volume (Units) by
Segment, Historic, 2000-2008 130
Table 86: Interventional Cardiology,
United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015 131
Table
87: Cardiac Catheter, United Kingdom, Volume (Units) by Sub-Segment,
Historic, 2000-2008 132
Table 88: Cardiac Catheter, United Kingdom,
Volume (Units) by Sub-Segment, Forecast, 2008-2015 133
Table 89:
Coronary Stent, United Kingdom, Volume (Units) by Sub-Segment, Historic,
2000-2008 134
Table 90: Coronary Stent, United Kingdom, Volume
(Units) by Sub-Segment, Forecast, 2008-2015 135
Table 91: PTCA
Balloon, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
136
Table 92: PTCA Balloon, United Kingdom, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 137
Table 93: Interventional
Cardiology, United Kingdom, Average Price ($), Historic, 2000-2008 138
Table 94: Interventional Cardiology, United Kingdom, Average Price ($),
Forecast, 2008-2015 139
Table 95: Interventional Cardiology, United
Kingdom, Distribution Share by Revenue ($mn), 2007-2008 140
Table 96:
Interventional Cardiology, United Kingdom, Company Share by Revenue ($ mn),
2007-2008 141
Table 97: Peripheral Vascular Devices, United Kingdom,
Revenue ($ mn) by Segment, Historic, 2000-2008 143
Table 98:
Peripheral Vascular Devices, United Kingdom, Revenue ($ mn) by Segment,
Forecast, 2008-2015 145
Table 99: Peripheral Vascular Devices, United
Kingdom, Volume (Units) by Segment, Historic, 2000-2008 147
Table 100:
Peripheral Vascular Devices, United Kingdom, Volume (Units) by Segment,
Forecast, 2008-2015 149
Table 101: Peripheral Vascular Devices,
United Kingdom, Average Price ($), Historic, 2000-2008 150
Table 102:
Peripheral Vascular Devices, United Kingdom, Average Price ($), Forecast,
2008-2015 150
Table 103: Peripheral Vascular Devices, United Kingdom,
Distribution Share by Revenue ($mn), 2007-2008 151
Table 104:
Peripheral Vascular Devices, United Kingdom, Company Share by Revenue ($ mn),
2007-2008 152
Table 105: Medtronic, Inc. Pipeline Products by
Equipment Type 156
Table 106: Medtronic, Inc. Pipeline Products By
Development Stage 158
Table 107: Medtronic, Inc. Pipeline Products By
Therapy Area 160
Table 108: Medtronic, Inc. Pipeline Products By
Clinical Trials 162
Table 109: Medtronic, Inc. Pipeline Products By
News Summaries 163
Table 110: Cordis Corporation Pipeline Products by
Equipment Type 164
Table 111: Cordis Corporation Pipeline Products By
Development Stage 164
Table 112: Cordis Corporation Pipeline Products
By Therapy Area 165
Table 113: Cordis Corporation Pipeline Products
By Clinical Trials 165
Table 114: Cordis Corporation Pipeline
Products By News Summaries 165
Table 115: Boston Scientific
Corporation Pipeline Products by Equipment Type 169
Table 116: Boston
Scientific Corporation Pipeline Products By Development Stage 170
Table
117: Boston Scientific Corporation Pipeline Products By Therapy Area
171
Table 118: Boston Scientific Corporation Pipeline Products By
Clinical Trials 172
Table 119: Boston Scientific Corporation Pipeline
Products By News Summaries 173
Table 120: St. Jude Medical Inc.
Pipeline Products by Equipment Type 178
Table 121: St. Jude Medical
Inc. Pipeline Products By Development Stage 178
Table 122: St. Jude
Medical Inc. Pipeline Products By Therapy Area 179
Table 123: St.
Jude Medical Inc. Pipeline Products By Clinical Trials 179
Table 124:
St. Jude Medical Inc. Pipeline Products By News Summaries 180
Table 125:
Terumo Corporation Pipeline Products by Equipment Type 183
Table 126:
Terumo Corporation Pipeline Products By Development Stage 183
Table
127: Terumo Corporation Pipeline Products By Therapy Area 183
Table
128: Terumo Corporation Pipeline Products By Clinical Trials 184
Table 129: Terumo Corporation Pipeline Products By News Summaries 184
Table 130: Sorin Group Pipeline Products by Equipment Type 188
Table
131: Sorin Group Pipeline Products By Development Stage 189
Table
132: Sorin Group Pipeline Products By Therapy Area 190
Table 133:
Sorin Group Pipeline Products By Clinical Trials 191
Table 134:
Sorin Group Pipeline Products By News Summaries 191
Table 135:
Thoratec Corporation Pipeline Products by Equipment Type 195
Table 136:
Thoratec Corporation Pipeline Products By Development Stage 195
Table
137: Thoratec Corporation Pipeline Products By Therapy Area 195
Table
138: Thoratec Corporation Pipeline Products By Clinical Trials 196
Table 139: Thoratec Corporation Pipeline Products By News Summary 196
Table 140: Philips Medical Systems Pipeline Products by Equipment Type
203
Table 141: Philips Medical Systems Pipeline Products By
Development Stage 203
Table 142: Philips Medical Systems Pipeline
Products By Therapy Area 204
Table 143: Philips Medical Systems
Pipeline Products By Clinical Trials 204
Table 144: Philips Medical
Systems Pipeline Products By News Summary 204
Table 145: Invatec
S.r.l. Pipeline Products by Equipment Type 212
Table 146: Invatec
S.r.l. Pipeline Products By Development Stage 213
Table 147: Invatec
S.r.l. Pipeline Products By Therapy Area 214
Table 148: Invatec
S.r.l. Pipeline Products By Clinical Trials 215
Table 149: Invatec
S.r.l. Pipeline Products By News Summary 215
Table 150: ev3 Inc.
Pipeline Products by Equipment Type 220
Table 151: ev3 Inc. Pipeline
Products By Development Stage 220
Table 152: ev3 Inc. Pipeline
Products By Therapy Area 221
Table 153: ev3 Inc. Pipeline Products By
Clinical Trials 221
Table 154: ev3 Inc. Pipeline Products By News
Summary 221
Table 155: Edwards Lifesciences Corporation Pipeline
Products by Equipment Type 225
Table 156: Edwards Lifesciences
Corporation Pipeline Products By Development Stage 225
Table 157:
Edwards Lifesciences Corporation Pipeline Products By Therapy Area 226
Table 158: Edwards Lifesciences Corporation Pipeline Products By Clinical
Trials 226
Table 159: Edwards Lifesciences Corporation Pipeline
Products By News Summary 227
Table 160: CryoCath Technologies Inc.
Pipeline Products by Equipment Type 231
Table 161: CryoCath
Technologies Inc. Pipeline Products By Development Stage 231
Table 162:
CryoCath Technologies Inc. Pipeline Products By Therapy Area 232
Table
163: CryoCath Technologies Inc. Pipeline Products By Clinical Trials
232
Table 164: CryoCath Technologies Inc. Pipeline Products By News
Summary 232
Table 165: Card Guard AG Pipeline Products by Equipment
Type 236
Table 166: Card Guard AG Pipeline Products By Development
Stage 236
Table 167: Card Guard AG Pipeline Products By Therapy Area
236
Table 168: C.R. Bard, Inc. Pipeline Products by Equipment Type
240
Table 169: C.R. Bard, Inc. Pipeline Products By Development Stage
240
Table 170: C.R. Bard, Inc. Pipeline Products By Therapy Area
241
Table 171: C.R. Bard, Inc. Pipeline Products By Clinical Trials
241
Table 172: BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment
Type 242
Table 173: BIOTRONIK GmbH & Co. KG Pipeline Products By
Development Stage 242
Table 174: BIOTRONIK GmbH & Co. KG Pipeline
Products By Therapy Area 243
Table 175: BIOTRONIK GmbH & Co. KG
Pipeline Products By Clinical Trials 243
Table 176: BIOTRONIK GmbH &
Co. KG Pipeline Products By News Summary 243
Table 177: AtriCure,
Inc. Pipeline Products by Equipment Type 245
Table 178: AtriCure,
Inc. Pipeline Products By Development Stage 245
Table 179: AtriCure,
Inc. Pipeline Products By Therapy Area 246
Table 180: AtriCure, Inc.
Pipeline Products By Clinical Trials 246
Table 181: AtriCure, Inc.
Pipeline Products By News Summary 246
Table 182: Arrow International,
Inc. Pipeline Products by Equipment Type 250
Table 183: Arrow
International, Inc. Pipeline Products By Development Stage 250
Table 184:
Arrow International, Inc. Pipeline Products By Therapy Area 250
Table
185: Arrow International, Inc. Pipeline Products By Clinical Trials
250
Table 186: ABIOMED, Inc. Pipeline Products by Equipment Type
254
Table 187: ABIOMED, Inc. Pipeline Products By Development Stage
254
Table 188: ABIOMED, Inc. Pipeline Products By Therapy Area
254
Table 189: ABIOMED, Inc. Pipeline Products By Clinical Trials
255
Table 190: ABIOMED, Inc. Pipeline Products By News Summary
255
Table 191: Abbott Laboratories Pipeline Products by Equipment
Type 259
Table 192: Abbott Laboratories Pipeline Products By
Development Stage 259
Table 193: Abbott Laboratories Pipeline
Products By Therapy Area 259
Table 194: Abbott Laboratories Pipeline
Products By News Summary 260
Table 195: AorTech International plc
Pipeline Products by Equipment Type 262
Table 196: AorTech
International plc Pipeline Products By Development Stage 262
Table 197:
AorTech International plc Pipeline Products By Therapy Area 262
Table
198: AorTech International plc Pipeline Products By News Summary 262
Table 199: Cardiak Ltd. Pipeline Products by Equipment Type 263
Table
200: Cardiak Ltd. Pipeline Products By Development Stage 263
Table
201: Cardiak Ltd. Pipeline Products By News Summary 264
Table 202:
Tayside Flow Technologies Limited Pipeline Products by Equipment Type
266
Table 203: Tayside Flow Technologies Limited Pipeline Products By
Development Stage 266
Table 204: Tayside Flow Technologies Limited
Pipeline Products By Therapy Area 266
Table 205: Tayside Flow
Technologies Limited Pipeline Products By Clinical Trials 267
Table 206:
Tayside Flow Technologies Limited Pipeline Products By News Summary 267
Table 207: Veryan Medical Pipeline Products by Equipment Type 270
Table 208: Veryan Medical Pipeline Products By Development Stage 270
Table 209: Veryan Medical Pipeline Products By Therapy Area 270
Table
210: Vascular Concepts Group Pipeline Products by Equipment Type 271
Table 211: Vascular Concepts Group Pipeline Products By Development Stage
271
Table 212: Vascular Concepts Group Pipeline Products By Therapy
Area 271
Table 213: Vascular Conc
|
Related Report
|
View Cart
